Oligofructose Enriched Inulin.

Colonic bacteria ferment inulin-type fructans into short chain fatty acids, which drop luminal pH and keep calcium soluble as the free ion. The lower pH also drives paracellular and transcellular calcium uptake across the large bowel wall.

The same acidification that mobilises calcium keeps magnesium in solution for absorption in the caecum and colon, a compartment ordinary magnesium salts largely bypass. Fructans therefore widen where a magnesium dose can be taken up.

Bifidobacteria carry beta-fructofuranosidases that cleave fructan chains, so oligofructose is a selective substrate this genus can use where many others cannot. Supplying the organism and its preferred substrate together is the definition of a synbiotic.

Short-chain fructooligosaccharides are fermentable by many lactobacilli, giving a delivered strain a carbon source on arrival in the colon. The pairing raises the chance the strain establishes rather than passing through.

Fructan fermentation by butyrate producers is the normal route to colonic butyrate, the main fuel for colonocytes. Supplying butyrate directly alongside its substrate covers both the immediate amount and the ongoing production.

Oligofructose ferments quickly in the proximal colon while resistant starch survives further and feeds distal populations. Combining them spreads short chain fatty acid production along the length of the bowel instead of concentrating it at the start.

Partially hydrolysed guar gum ferments slowly and evenly, which moderates the rapid gas production oligofructose can cause on its own. Formulators blend a fast and a slow fermentable fibre for that reason.

Akkermansia grazes on mucin and exchanges fermentation products with fructan-degrading bifidobacteria, so a fructan substrate feeds it indirectly through cross-feeding. The pairing supports the mucus-associated end of the community rather than the substrate-degrading end alone.

The pH drop from fructan fermentation keeps zinc soluble in the large bowel and has been reported to raise apparent zinc absorption. The mechanism is the same one that applies to calcium and magnesium.

Fermentation acids can keep iron soluble past the duodenum and raise uptake across the colon, a route unsupplemented iron makes little use of. The effect is smaller and less consistent than for calcium.

FOS is the short-chain end of the same beta 2 to 1 fructan family that oligofructose belongs to, so adding it to an oligofructose-enriched inulin mostly raises short-chain fructan dose. That is a dose increase on one substrate rather than a second mechanism. Short-chain fructans ferment fast in the proximal colon, which is where gas tolerance tends to be tested.

Psyllium is a poorly fermented gel-forming fibre that holds water and adds stool bulk, while fructans are readily fermented and produce gas. Pairing a gelling fibre with a fermentable one covers two different fibre functions in one product. It also means the fermentable share of the total fibre dose can be kept lower for tolerance.

Pectin is a galacturonic acid polymer whose fermentation favours acetate, while fructan fermentation contributes more lactate and butyrate through cross-feeding. A blend gives a broader short-chain fatty acid mix. What each fibre yields depends heavily on the individual microbiota it meets.

Glucomannan forms a very viscous gel at low doses, slowing gastric emptying, which fructans do not do. Combining the two adds a viscosity mechanism to a fermentation mechanism. Viscous fibres need adequate fluid, which is a practical point in any blend.

Bifidobacteria carry beta-fructofuranosidase activity that cleaves fructan chains, which is why fructans are the classical substrate for this genus. Supplying the substrate alongside the organism gives the organism something to ferment on arrival. This describes substrate use, and any downstream effect depends on the resident community too.

Lactobacillus plantarum can use short-chain oligosaccharides, and lactate produced by lactobacilli is cross-fed by butyrate producers in the colon. Pairing an organism with a fermentable substrate is the definition of a synbiotic formulation. Strain-level differences in fructan use are large, so the pairing is not automatic.

Saccharomyces boulardii is a yeast, not a lactic acid bacterium, and it does not depend on fructans as a substrate the way bifidobacteria do. Combining it with a fructan means the fibre feeds the resident bacteria while the yeast acts on its own. That is a complementary pairing rather than a substrate-organism match.

Active vitamin D drives calbindin-mediated active calcium transport in the duodenum, while fermentable fructans lower colonic pH and increase the soluble calcium available for passive uptake further down. The two act on different segments by different routes. Both concern absorption of the mineral, not bone density.

Colonic bacteria synthesise long-chain menaquinones, and the amount depends on which organisms are present and what they are fed. A fermentable fructan shifts that community, which is a plausible but unquantified route to menaquinone supply. Supplemental MK-7 does not depend on that route, which is why the two are complementary.

Quercetin glycosides that escape small intestinal absorption are deglycosylated and further metabolised by colonic bacteria. A fermentable substrate that shifts that community can change the metabolite profile produced from the flavonoid. The direction is established microbiology; the size of the shift in a person is not.

Urolithins are produced from dietary ellagitannins only by specific gut bacteria, which is why some people convert and some do not. A fermentable fructan feeding the colonic community is relevant to that conversion capacity, though it does not create it. Pre-formed urolithin A bypasses the conversion step entirely.

Unabsorbed catechins reach the colon where bacteria ring-cleave them into smaller phenolic metabolites. Shifting the fermenting community with a fructan can shift which metabolites appear. This concerns metabolite profiles, a marker-level observation.

Resistant dextrin is a glucose-based fibre fermented more slowly than short-chain fructans, so it reaches further down the colon. Blending it with a fructan spreads fermentation over a longer stretch of bowel. Total fermentable dose still governs gas production.

Lactase hydrolyses lactose in the small intestine so it does not reach the colon to be fermented, whereas fructans are designed to reach the colon and be fermented. In someone with both lactose and fructan sensitivity, the two produce similar bloating from different causes. Separating the causes is the practical point.

Fructan fermentation lowers luminal pH in the colon, and mineral solubility rises as pH falls, which is the mechanism usually cited for mineral absorption effects. Most iron uptake, however, happens in the duodenum well before that fermentation occurs. So the mechanism is real in the colon and largely irrelevant to a chelated iron dose taken with a meal.

Human pancreatic and brush-border enzymes cannot hydrolyse beta 2 to 1 fructan linkages, which is exactly why these fibres reach the colon intact. A standard digestive enzyme blend does not change that. Only a microbial inulinase or fructanase would, and that is a different enzyme class.